Business Wire

Seasonic’s New High Efficiency 1.6 kW Platform for Broad Power Supply Portfolio Use Built With Transphorm GaN

Jaa

Transphorm Inc.— the leader in the design and manufacturing of the highest reliability and first JEDEC- and AEC-Q101 qualified gallium nitride (GaN) semiconductors—today announced that Seasonic Electronics Co. uses Transphorm’s high voltage (HV) GaN FETs in its new 1600 Watt (W) bridgeless totem-pole power factor correction (PFC) platform: the 1600T. The 1600T is the power supply manufacturer’s highest performing PFC platform to date at greater than 99 percent efficiency. Notably, the introduction of GaN delivers a two percent efficiency increase and 20 percent power density increase over Seasonic’s previous Silicon-based platform.

The 1600T platform will be scaled and deployed in various catalog products targeting the Charger (e-scooters, industrial, etc.), Gaming, Server, and PC power markets.

“When researching semiconductor technologies that would enable us to reach world-leading efficiency levels, gallium nitride stood out as an attractive alternative to Silicon,” said Paul Lin, Director of Research and Development, Seasonic. “We knew the bridgeless totem-pole PFC was the topology we would use in our first high voltage GaN power platform. So, we needed power semiconductors capable of successfully capitalizing on that topology. What’s more, we wanted a GaN solution that could be backed by our standard warranty. We ultimately opted for Transphorm’s FETs within the 1600T given their proven performance and reliability that allowed us to meet those requirements.”

Designing with Confidence: Transphorm Q+R

The 1600T platform employs Transphorm’s TP65H035WS device, a 650 V GaN FET with an RDS(on) of 35 mΩ in a standard TO-247 package. The transistor achieves increased efficiency in hard-and soft-switched circuits, providing power systems engineers options when designing products. Further, the TP65H035WS pairs with commonly-used gate drivers to simplify designs while controlling costs.

Transphorm prioritizes quality and reliability (Q+R) when developing its GaN platforms and FETs. An outcrop of that prioritization is increased safety for designers; Transphorm GaN typically delivers greater headroom and noise immunity when compared to other available GaN FETs. The TP65H035WS’ typical gate threshold is 4 V with a maximum gate voltage of ±20 V.

Beyond the technology itself, Transphorm offers in-depth field application support and hands on training given GaN’s relative newness in high voltage applications. Seasonic leveraged the semiconductor company’s experts to strengthen the design itself while quickening time to market.

For example, guidance provided helped Seasonic’s team ramp on use of a simple, low-cost digital signal processor (DSP) to control the totem-pole PFC. Transphorm also aided in the platform’s component selection and system layout, ensuring optimal GaN performance. Ultimately, the co-development directly impacted Seasonic’s ability to drive up thermal efficiency while increasing power output—generating a HV GaN platform capable of delivering on Seasonic’s vision.

About Seasonic Electronics

Seasonic is a truly global company. Headquartered in Taipei, Taiwan, we export our products from our factory in China to our offices in the USA, Europe, Japan, as well as to other parts of the world. As a leader in innovation, our company’s main focus is to bring the latest technology at the best possible value to all our customers, who require cutting-edge features combined with market leading performance and total reliability. The strong competition in the IT industry gives us constant challenges, which strengthen our resolve to become and stay the best. Today, the Seasonic name is the equivalent of high performance, excellence and reliability. Our design and engineering team is passionate about creating new solutions that reply to the needs of our customers and connect to the latest market trends.

About Transphorm

Transphorm (transphormusa.com) designs, manufactures, and sells the highest performance, highest reliability GaN semiconductors for high-voltage power conversion applications. Holding one of the largest Power GaN IP portfolios (1000+ issued and pending patents worldwide), Transphorm produces the industry’s only JEDEC and AEC-Q101 qualified GaN FETs. This is due to a vertically-integrated business approach, which allows for innovation at every stage: materials and device design and manufacture, fabrication, packaging, reference circuit designs, and application support.

Contact information

Crimson Communicates
Heather Ailara, 845-424-6341
heather@crimsoncom.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Life-Sciences and Healthcare Communications Leaders John “Zeke” Czekanski and Scott Roberts Join Citrus Global Healthcare Communications Group as Managing Partners21.3.2019 17:21:00 EETTiedote

Industry leaders John “Zeke” Czekanski and Scott Roberts have joined Citrus Global Healthcare Communications Group as Managing Partners. Zeke will oversee Citrus Scientific while Scott brings his extensive global market access and value experience in guiding Citrus Access. Together they will actively co-manage Citrus Strategy, providing insights enabling clients to innovate with confidence, broaden opportunities, and drive meaningful human-health outcomes forward. “I’m thrilled to be part of the Citrus Group working in partnership with our clients, the medical community, payers, government agencies, and global healthcare stakeholders. We look forward to delivering meaningful scientific insights and market-access solutions,” commented Zeke. Scott added, “There is a critical need in our industry, especially with highly innovative small to mid-size life-science companies, for a transformational agency applying data and analytics along with a holistic approach to the communications continu

Abzena Announces New Fully Integrated Developability and Optimization Service to Improve Lead Selection and De-risk Biologic Cell Line Development21.3.2019 16:44:00 EETTiedote

Abzena, the leading biologics target to GMP partner research organisation (PRO), announced its Cambridge UK site has brought together its extensive discovery, immunogenicity assessment, protein engineering, formulation, bioassay and analytical expertise to launch a developability assessment and optimization service to assist customers in selecting and developing the best lead candidate to take forward for manufacture. The new Developability Service reduces the time, risk and cost required to take multiple lead candidates through cell line development and manufacturing. Biologics have potential liabilities for safety, functionality, stability and scalability and when these issues are identified early alternate leads can be selected, liabilities engineered out or measures can be taken to mitigate risk. The Developability Service also enables the selection of drug candidates most aligned with the target product profile by evaluating a range of functionality and specificity readouts. The s

XPRIZE Identifies 10 Future Breakthroughs Required to Protect Our Forests21.3.2019 16:27:00 EETTiedote

Today, on the United Nations’ International Day of Forests, XPRIZE is releasing the Future of Forests Impact Roadmap, created in partnership with Kimberly-Clark Corporation. The digital report and its interactive website, based on future foresight techniques, illustrate the breakthroughs required for a healthier forest ecosystem, which might be the basis of future XPRIZE competitions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190321005409/en/ Across the world, forests provide food security and shelter, protect biodiversity and house indigenous populations. While forests cover more than 30 percent of the Earth’s surface, more than 32 million acres of forests are lost due to human activity every year, with research showing that continued mass deforestation and degradation is accelerating climate change. XPRIZE designs and operates global competitions to incentivize the development of technological breakthroughs that accel

Mark Thorne Joins BCW as Global Chief Financial Officer and Chief Operating Officer21.3.2019 16:17:00 EETTiedote

BCW (Burson Cohn & Wolfe), a leading global communications agency, announced today that Mark Thorne has been appointed Global Chief Financial Officer and Chief Operating Officer, effective immediately. Thorne will be a strategic partner to BCW Global CEO Donna Imperato in transforming the agency’s financial model to better reflect its wide range of services and offerings. He is based in New York and replaces Pat Przybyski, formerly Global Chief Financial Officer. “Mark is well known for his strong business acumen, deep operational experience and high-level strategic thinking,” said Imperato. “I have known Mark for many years and am thrilled to now call him my partner. He is the right leader to help BCW execute our strategies and grow exponentially.” Thorne spent the past 20 plus years with Hill+Knowlton Strategies in a range of leadership roles, most recently serving as Global Chief Financial Officer and Global Chief Operating Officer. Prior to that, Thorne was Executive Vice President

Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds21.3.2019 16:09:00 EETTiedote

Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million Series B financing led by Omega Funds, a leading international investment firm that creates and invests in life sciences companies. Other investors participating in the round include existing investors Frazier Healthcare Partners, Amgen Ventures, and MRL Ventures Fund as well as HighLight Capital, Pharmaron and Greenspring Associates. Dr. Dina Chaya from Omega Funds will join the board of directors and Dennis Henner will remain Chairman of the Board, representing his fund. “Imago BioSciences is extremely gratified with the interest and support of the investment community; we are particularly pleased with the composition of this new investment syndicate,” said Hugh Young Rienhoff, Jr. M.D., CEO at Imago BioSciences. “These funds will enable Imago to advance our programs through the completion of Phase 2b studies.” “We are excited to work wi

Workiva Wins DevOps Excellence Award in London21.3.2019 16:03:00 EETTiedote

Workiva (NYSE:WK), the leading cloud provider of connected data, reporting and compliance solutions, today announced that its Wdesk platform was named the Best Software-Defined Product, last night at Computing's DevOps Excellence Awards dinner. The Computing DevOps Excellence Awards recognize outstanding achievement from organisations, personalities and solutions operating within the DevOps industry. Winners were selected on their superior functionality, level of ability to modernize business processes, positive customer feedback and a strong return on investment. “We are proud to win this prestigious award,” said Marty Vanderploeg, CEO of Workiva. “As the global leader in connected reporting, XBRL and Inline XBRL, our Wdesk platform helps customers all over the world consolidate, connect and tag their data in a single, cloud environment so they are able to reduce risk and save time when filing reports with various regulators and other stakeholders.” XBRL (eXtensible Business Reporting

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme